- Title
- Innovative strategies for the elimination of viral hepatitis at a national level: a country case series
- Creator
- Schröeder, Sophia E.; Pedrana, Alisa; Getahun, Aneley; Hamid, Saeed; Hammad, Radi; 't Hoen, Ellen; Hutchinson, Sharon J.; Lazarus, Jeffrey V.; Lesi, Olufunmilayo; Li, Wangsheng; Binti Mohamed, Rosmawati; Olafsson, Sigurdur; Scott, Nick; Peck, Raquel; Sohn, AH; Sonderup, M; Spearman, CW; Swan, T; Thursz, M; Walker, Tim; Hellard, M; Howell, J; Wilson, David; Kuschel, Christian; Aufegger, Lisa; Atun, Rifat; Baptista-Leite, Ricardo; Butsashvili, Maia; El-Sayed, Manal
- Relation
- Liver International Vol. 39, Issue 10, p. 1818-1836
- Publisher Link
- http://dx.doi.org/10.1111/liv.14222
- Publisher
- Wiley-Blackwell
- Resource Type
- journal article
- Date
- 2019
- Description
- Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost-effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence-gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints.
- Subject
- developing countries; disease elimination; hepatitis B; hepatitis C; investment case; organizational case studies; SDG 3; SDG 17; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1469955
- Identifier
- uon:48352
- Identifier
- ISSN:1478-3223
- Rights
- © 2019 The Authors. Liver International published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Language
- eng
- Full Text
- Reviewed
- Hits: 10134
- Visitors: 9618
- Downloads: 150
Collections
Goal 3: Good Health and Well-Being
Goal 17: Partnerships for the Goals
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT02 | Publisher version (open access) | 2 MB | Adobe Acrobat PDF | View Details Download |